Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
248 studies found for:    "ankylosing spondylitis"
Show Display Options
Rank Status Study
1 Completed Study Investigating Enbrel Treatment for Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Intervention: Drug: Etanercept
2 Active, not recruiting Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)
Condition: Ankylosing Spondylitis
Intervention:
3 Completed
Has Results
A Study of Adalimumab in Japanese Subjects With Active Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Intervention: Biological: adalimumab
4 Completed Effect of the Combination of Methotrexate and Adalimumab on Reduction of Immunization in Ankylosing Spondylitis (COMARIS)
Condition: Ankylosing Spondylitis
Interventions: Drug: Adalimumab;   Drug: Methotrexate
5 Recruiting Study of Efficacy and Safety of Secukinumab in Japanese Patients With Active Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Intervention: Drug: secukinumab 150mg
6 Completed
Has Results
Double Blind, Placebo Controlled Study to Assess Efficacy of AIN457 in Moderate to Severe Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Interventions: Biological: AIN457;   Drug: Placebo
7 Completed
Has Results
Study Evaluating Etanercept and Sulphasalazine in Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Interventions: Drug: etanercept;   Drug: sulphasalazine (SSZ)
8 Completed
Has Results
Study Evaluating Predictors of Response in Patients With Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Intervention: Other: Treatment switching
9 Active, not recruiting Post-authorization Safety Study of Etoricoxib and Other Anti-inflammatory Therapies in European Patients With Ankylosing Spondylitis (MK-0663-163)
Condition: Ankylosing Spondylitis
Intervention:
10 Recruiting Physical Training Program in Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Intervention: Other: Personalized physical training program
11 Recruiting Canadian Humira Post Marketing Observational Epidemiological Study: Assessing Effectiveness in Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Intervention:
12 Completed
Has Results
Study Evaluating Etanercept in Subjects With Ankylosing Spondylitis in Spain
Condition: Ankylosing Spondylitis
Interventions: Drug: etanercept;   Drug: etanercept/placebo
13 Completed Phase II Clinical Study of Thalidomide in the Treatment of Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Interventions: Drug: Thalidomide 150mg;   Drug: Thalidomide 100mg;   Drug: Placebo
14 Completed
Has Results
Safety and Efficacy of Adalimumab in Patients With Active Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Interventions: Biological: adalimumab (D2E7);   Biological: placebo
15 Completed A Study of Infliximab (Remicade) in Patients With Ankylosing Spondylitis.
Condition: Ankylosing Spondylitis
Intervention: Drug: infliximab
16 Completed
Has Results
Efficacy and Safety of Adalimumab in Adult Chinese Subjects With Active Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Interventions: Biological: adalimumab;   Other: placebo
17 Unknown  European Ankylosing Spondylitis Infliximab Cohort (EASIC) Follow up Registration Study
Condition: Ankylosing Spondylitis
Intervention:
18 Completed
Has Results
Study Evaluating Etanercept for the Treatment of Active, Severe, and Advanced Axial Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Interventions: Drug: Etanercept (Enbrel);   Other: Placebo
19 Unknown  Examination of Radiographic Progression, Efficacy and Safety of Long-Term Treatment With Infliximab in Patients With Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Intervention: Drug: infliximab
20 Unknown  Methotrexate in Ankylosing Spondylitis (MTX in AS)
Condition: Ankylosing Spondylitis
Intervention: Drug: Methotrexate

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.